DE3685818T2 - Immunkomplextestverfahren. - Google Patents

Immunkomplextestverfahren.

Info

Publication number
DE3685818T2
DE3685818T2 DE8686301682T DE3685818T DE3685818T2 DE 3685818 T2 DE3685818 T2 DE 3685818T2 DE 8686301682 T DE8686301682 T DE 8686301682T DE 3685818 T DE3685818 T DE 3685818T DE 3685818 T2 DE3685818 T2 DE 3685818T2
Authority
DE
Germany
Prior art keywords
associated antigen
tumor associated
immune complexes
test procedure
immune complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686301682T
Other languages
English (en)
Other versions
DE3685818D1 (de
Inventor
Anil K Singhal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imre Corp
Original Assignee
Imre Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imre Corp filed Critical Imre Corp
Publication of DE3685818D1 publication Critical patent/DE3685818D1/de
Application granted granted Critical
Publication of DE3685818T2 publication Critical patent/DE3685818T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE8686301682T 1986-03-10 1986-03-10 Immunkomplextestverfahren. Expired - Fee Related DE3685818T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86301682A EP0236606B1 (de) 1986-03-10 1986-03-10 Immunkomplextestverfahren

Publications (2)

Publication Number Publication Date
DE3685818D1 DE3685818D1 (de) 1992-07-30
DE3685818T2 true DE3685818T2 (de) 1993-01-14

Family

ID=8195922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301682T Expired - Fee Related DE3685818T2 (de) 1986-03-10 1986-03-10 Immunkomplextestverfahren.

Country Status (4)

Country Link
EP (1) EP0236606B1 (de)
JP (1) JPS62231172A (de)
AT (1) ATE77700T1 (de)
DE (1) DE3685818T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326814C (en) * 1987-08-11 1994-02-08 Eiji Ishikawa Method of high sensitivity immunoassay
US5236849A (en) * 1987-08-11 1993-08-17 Eiji Ishikawa Method of high sensitivity immunoassay
JP2657672B2 (ja) * 1987-08-11 1997-09-24 栄治 石川 超高感度特異的抗体の測定法
JP2606722B2 (ja) * 1988-04-05 1997-05-07 栄治 石川 超高感度抗原物質の測定法
US5236830A (en) * 1988-11-10 1993-08-17 Eiji Ishikawa Method of assay for antigen
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
AT409801B (de) * 2000-05-31 2002-11-25 Cistem Biotechnologies Gmbh Verfahren zum screenen und isolieren von mikroorganismen, insbesondere prokaryontischer und eukaryontischer zellen, die ein antigen präsentieren
GB2395270B (en) 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
SI1889059T1 (sl) 2005-05-27 2009-12-31 Oncimmune Ltd Izboljšani imunotestni postopek
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
CN112379093B (zh) * 2020-10-22 2023-06-16 上海良润生物医药科技有限公司 CST-Cathepsin复合物作为肿瘤诊断标志物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508133A (en) * 1975-05-20 1978-04-19 Technicon Instr Biological analysis
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
JPS60192263A (ja) * 1984-03-13 1985-09-30 Teijin Ltd 免疫複合体測定用標準物質及びそれを用いた免疫複合体の測定法

Also Published As

Publication number Publication date
EP0236606A1 (de) 1987-09-16
DE3685818D1 (de) 1992-07-30
EP0236606B1 (de) 1992-06-24
JPS62231172A (ja) 1987-10-09
ATE77700T1 (de) 1992-07-15

Similar Documents

Publication Publication Date Title
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
EP0212489A3 (en) Anabolic activity modulator and uses thereof
DE3685818T2 (de) Immunkomplextestverfahren.
JPS57200862A (en) Mutilayer analysis element utilizing unique binding reaction
IT1177121B (it) Metodo per determinare i complessi immuni nel siero
ATE97495T1 (de) Bestimmung mit affinitaetssubstanzen und hplcschritt.
DE3584796D1 (de) Verfahren und vorrichtung zur durchfuehrung analytischer bestimmungen.
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
DE3485265D1 (de) Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer.
ATE50459T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
DE3874741D1 (de) Immunassay-verfahren.
ATE61485T1 (de) Verfahren und hilfsmittel zur vorbehandlung von seren zum bestimmen von dizoxin und dabei erhaltenes dizoxinkonzentrat.
ATE22997T1 (de) Verfahren zur immunologischen bestimmung, unter verwendung zweier antikoerper, wobei der zweite antikoerper durch affinitaetschromatographie gereinigt ist, und traeger dafuer.
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
MY103043A (en) Swine dysentery vaccine
ATE64466T1 (de) Immuntest.
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.
SE8600543D0 (sv) Diagnostiskt test for detektering av antikroppar i kroppsvetskor
ATE57022T1 (de) Verfahren zur bestimmung von parathormon.
IT8606606A0 (it) Test immunoenzimatico per la ricerca anticorpi anti-insulina nel siero
CS555888A1 (en) Method of pure specific antibodies production for proteins concentration's quick quantitative determination

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee